In BEA, a dose-response assessment uses which of the following to estimate health impacts?

In BEA, a dose-response assessment uses which of the following to estimate health impacts?

• A. To measure only the color of contaminants.
• B. To assess facility layout efficiency.
• C. To estimate health impact given exposure levels and hazard characteristics.
• D. To determine PPE purchase cost.

Answer: (C)

The main idea is that dose-response links how much someone is exposed to a contaminant with how toxic that contaminant is, so you can estimate the health effects on people. In BEA, you combine exposure levels (how much, how long, and how many people are exposed) with the hazard characteristics of the contaminant (its toxicity, potency, and the dose–response relationship) to estimate health impacts. This is how you translate contact with a substance into a quantified risk, such as noncancer hazard or cancer risk, for a population. That’s why estimating health impact given exposure levels and hazard characteristics is the best fit. The other options don’t address health effects: color isn’t related to toxicity, facility layout efficiency isn’t about health risk, and PPE cost is an economic consideration, not the health impact estimate derived from dose–response.

The main idea is that dose-response links how much someone is exposed to a contaminant with how toxic that contaminant is, so you can estimate the health effects on people. In BEA, you combine exposure levels (how much, how long, and how many people are exposed) with the hazard characteristics of the contaminant (its toxicity, potency, and the dose–response relationship) to estimate health impacts. This is how you translate contact with a substance into a quantified risk, such as noncancer hazard or cancer risk, for a population.

That’s why estimating health impact given exposure levels and hazard characteristics is the best fit. The other options don’t address health effects: color isn’t related to toxicity, facility layout efficiency isn’t about health risk, and PPE cost is an economic consideration, not the health impact estimate derived from dose–response.